top of page
Companies in the News
Jun 26, 2019
Encoded Therapeutics, Inc. Announces $104 Million Series C Financing to Advance Lead Gene Therapy Pr
Lead gene therapy candidate significantly reduced seizures and reversed early mortality in preclinical model of Dravet Syndrome Company...
Jun 13, 2019
BlackThorn Therapeutics Closes $76 Million Series B to Advance Targeted Therapeutics for Mental Heal
Company Also Expands Board of Directors and Executive Management Team with Key Appointments San Francisco – June 13, 2019 – BlackThorn...
Jun 12, 2019
Indigo launches The Terraton Initiative™ to remove one trillion tons of carbon dioxide from the atmo
At record levels of 415 parts per million (ppm), the Earth’s atmosphere contains one trillion tons (one teraton) more carbon dioxide...


May 15, 2019
A four-year-old start-up called Indigo Ag is the No. 1 company on the 2019 CNBC Disruptor 50 list
This Boston-based agricultural technology start-up is creating seed treatments that optimize the health of a plant in order to increase...
Apr 30, 2019
Vividion Secures $82 Million to Advance Its Lead Programs into the Clinic
Vividion Therapeutics snagged $82 million in an oversubscribed Series B funding round to bolster its cash holdings that will be used to...
Apr 22, 2019
Gritstone Oncology Announces Clinical Acceleration of “Off-The-Shelf” Personalized Neoantigen Immuno
EMERYVILLE, Calif., April 22, 2019 (GLOBE NEWSWIRE) -- Gritstone Oncology, Inc. (Nasdaq: GRTS), an immuno-oncology company developing...
Apr 2, 2019
BlackThorn Therapeutics Announces Positive Phase 1 Results for Its Selective KOR Antagonist, BTRX-33
Phase 1 results and new translational data supporting the development of BTRX-335140 for neurobehavioral disorders presented at the Kappa...
Mar 12, 2019
Indigo Agriculture and Anheuser-Busch Partner To Meet Sustainability Goals for Rice Production
BOSTON--(BUSINESS WIRE)--Indigo Agriculture, a company dedicated to harnessing nature to help farmers sustainably feed the planet, and...
Mar 7, 2019
Beam Brings In $135M to Turn CRISPR Base Editing into Drugs
Beam Therapeutics made a splash last year when it launched with $87 million to develop medicines that use a more precise form of CRISPR...
bottom of page